Two replicate phase 3 trials of GB-0895, an anti-thymic stromal lymphopoietin antibody, are enrolling adults and adolescents ...

A vaccine in development would be the first proactive treatment for overdose and fentanyl addiction, if approved. A vaccine ...

Calcium (Ca2+) drives many cellular functions, though the way it controls quality of proteins in the endoplasmic reticulum ...

HONOLULU (KHON2) – The next phase of Honolulu’s Skyline rail is set to open Thursday, Oct. 16, adding four new stops from Aloha Stadium to Middle Street. Around the clock testing starts for phase 2 of ...

HONOLULU (KHON2) — The second phase of Skyline has taken two years and three months, and it’s finally ready to open, with many expecting big changes to their commute. Skyline stations transform into ...

Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...

A new development in Rochester, known as The Ridge phase 2, is planned to include housing, commercial buildings, and a hospital emergency department. Developers are seeking a permit recommendation ...

Aug 27 (Reuters) - A unit of U.S. energy company Sempra (SRE.N), opens new tab will supply 2 million tonnes per annum (Mtpa) of liquefied natural gas from the Port Arthur LNG Phase 2 development ...

Jesse Zanger is the managing editor of CBSNewYork.com. Jesse has previously worked for the Fox News Channel and Spectrum News NY1. He covers regional news around the Tri-State Area, with a particular ...

LNG Canada awarded Flour Corp.’s joint venture with JGC Corp. the contract to update the front-end engineering and design (FEED) for a proposed Phase 2 expansion of the 14-million tonne/year LNG ...

A cinematic obsessive with the filmic palate of a starving raccoon, Rob London will watch pretty much anything once. With a mind like a steel trap, he's an endless fount of movie and TV trivia, borne ...

LOS ANGELES--(BUSINESS WIRE)--Pelage Pharmaceuticals, a clinical-stage regenerative medicine company, today announced positive results from its Phase 2a clinical trial of PP405 — a topical therapy for ...